Table of Contents

company-logo

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Kronos Bio Dividend Announcement

• Kronos Bio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Kronos Bio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Kronos Bio Dividend History

Kronos Bio Dividend Yield

Kronos Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Kronos Bio stock? Use our calculator to estimate your expected dividend yield:

Kronos Bio Financial Ratios

P/E ratio-0.51
PEG ratio0.01
P/B ratio0.43
ROE-68.82%
Payout ratio0.00%
Current ratio8.49
Quick ratio8.49
Cash Ratio4.22

Kronos Bio Dividend FAQ

Does Kronos Bio stock pay dividends?
Kronos Bio does not currently pay dividends to its shareholders.
Has Kronos Bio ever paid a dividend?
No, Kronos Bio has no a history of paying dividends to its shareholders. Kronos Bio is not known for its dividend payments.
Why doesn't Kronos Bio pay dividends?
There are several potential reasons why Kronos Bio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Kronos Bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Kronos Bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Kronos Bio a dividend aristocrat?
Kronos Bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kronos Bio a dividend king?
Kronos Bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kronos Bio a dividend stock?
No, Kronos Bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Kronos Bio stocks?
To buy Kronos Bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Kronos Bio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.